摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯-5-硝基肉桂酸 | 36015-19-7

中文名称
2-氯-5-硝基肉桂酸
中文别名
——
英文名称
(E)-3-(2-chloro-5-nitrophenyl)-2-propenoic acid
英文别名
3-(2'-chloro-5'-nitrophenyl)-2-propenoic acid;(E)-3-(2-chloro-5-nitrophenyl)acrylic acid;2-chloro-5-nitrocinnamic acid;2-chloro-5-nitro cinnamic acid;2-chloro-5-nitro-trans-cinnamic acid;2-Chlor-5-nitro-trans-zimtsaeure;(E)-3-(2-chloro-5-nitrophenyl)prop-2-enoic acid
2-氯-5-硝基肉桂酸化学式
CAS
36015-19-7
化学式
C9H6ClNO4
mdl
——
分子量
227.604
InChiKey
IHTLKLSRRSWIGD-DAFODLJHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    218-222 °C
  • 沸点:
    401.7±35.0 °C(Predicted)
  • 密度:
    1.529±0.06 g/cm3 (20 ºC 760 Torr)
  • 稳定性/保质期:
    常规情况下不会分解,没有危险反应。

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    83.1
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 安全说明:
    S24/25
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2916399090
  • 危险性防范说明:
    P264,P280,P302+P352+P332+P313+P362+P364,P305+P351+P338+P337+P313
  • 危险性描述:
    H315,H319
  • 储存条件:
    密封、阴凉、干燥、通风保存。

SDS

SDS:f27c7b4e4740880282226a8b4a88cd8f
查看
Name: 2-Chloro-5-Nitrocinnamic Acid 98% Predominantly Trans Material Safety Data Sheet
Synonym: 3-(2-Chloro-5-Nitrophenyl)acrylic Aci
CAS: 36015-19-7
Section 1 - Chemical Product MSDS Name:2-Chloro-5-Nitrocinnamic Acid 98% Predominantly Trans Material Safety Data Sheet
Synonym:3-(2-Chloro-5-Nitrophenyl)acrylic Aci

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
36015-19-7 2-Chloro-5-Nitrocinnamic Acid 98% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 36015-19-7: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: yellow crystalline powder
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 218 - 220 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H6ClNO4
Molecular Weight: 227.61

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong bases, strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 36015-19-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Chloro-5-Nitrocinnamic Acid - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 36015-19-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 36015-19-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 36015-19-7 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

聚合物/大分子半导体砌块

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氯-5-硝基肉桂酸盐酸 、 tin(II) chloride dihdyrate 作用下, 以 环丁砜乙醇 为溶剂, 反应 28.25h, 生成 3-amino-7,8,11b(11)-triazabenzo[c]fluorene hydrochloride
    参考文献:
    名称:
    新型咪唑并[4,5- b ]吡啶和三氮杂苯并[ c ]芴衍生物:合成,抗增殖活性和DNA结合研究
    摘要:
    在本论文中,我们已经描述了咪唑并[4,5的新衍生物的合成和生物活性b ]吡啶和三氮杂-苯并[ Ç ]芴(7 - 21,24 - 26,28 - 29)。这些化合物中的大多数以剂量依赖的方式对七种人类肿瘤细胞系产生了强大的细胞抑制作用。特别地,咪唑并[4,5- b ]吡啶和包括2-咪唑啉基衍生物的三氮杂-苯并[ c ]芴具有最有效的抗肿瘤活性。同样,三氮杂苯并[ c ]芴18和20在正常的人类成纤维细胞中诱导了对测试的肿瘤细胞系的强生长抑制作用,并显示出低细胞毒性。这些化合物的DNA相互作用研究表明,N-甲基化的16和2-咪唑啉基28三氮杂苯并[ c ]芴以嵌入方式与DNA结合。
    DOI:
    10.1016/j.ejmech.2011.03.062
  • 作为产物:
    描述:
    参考文献:
    名称:
    The Internal Michael Reaction. II. Formation of Arylated Coumarans, of an Indoline, a Dihydrothionaphthene and a Hydrocarbostyril1
    摘要:
    DOI:
    10.1021/ja01161a094
点击查看最新优质反应信息

文献信息

  • 一种石蒜碱β-芳基丙烯酸酯衍生物及其制备方法和用途
    申请人:山东达因海洋生物制药股份有限公司
    公开号:CN113416199B
    公开(公告)日:2022-03-01
    本申请提供一种石蒜碱β‑芳基丙烯酸酯衍生物及其制备方法和应用。所述石蒜碱β‑芳基丙烯酸酯衍生物具有式I所示结构:其中,Ar为C6‑12芳烃或C3‑10芳杂环,所述的芳杂环中的杂原子选自N、O、S;R为Ar上的取代基,为单取代或多取代,R独立地选自氢、卤素、卤代C1‑6烷基、卤代C1‑6烷氧基、硝基、羟基、C1‑6烷基、C1‑6烷氧基、C2‑6链烯基氧基、C2‑6烯基、C3‑6环烷基、苯基。所述石蒜碱β‑芳基丙烯酸酯衍生物具有良好的抗肿瘤活性,具有较好的药用前景。
  • Benzoxazepinones and their use as squalene synthase inhibitors
    申请人:——
    公开号:US20030078251A1
    公开(公告)日:2003-04-24
    There is disclosed a compound represented by the formula [I]: 1 wherein R 1 is optionally substituted 1-carboxyethyl group, optionally substituted alkyl-sulfonyl group, optionally substituted (carboxy-cycloalkyl)-alkyl group, —X 1 —X 2 —Ar—X 3 —X 4 —COOH (wherein X 1 and X 4 are a bond or alkylene group, X 2 and X 3 are a bond, —O—, —S—, Ar is divalent aromatic group etc.), R 2 is alkyl group optionally substituted with alkanoyloxy group and/or hydroxy group, R 3 is alkyl group, and W is halogen atom, etc., or a salt thereof. The compound has the cholesterol lowering activity and the triglyceride lowering activity and is useful for preventing and/or treating hyperlipidemia.
    披露了一种由公式[I]表示的化合物: 1 其中R 1 是可选地取代的1-羧乙基,可选地取代的烷基亚磺酰基,可选地取代的(羧基环烷基)-烷基,—X 1 —X 2 —Ar—X 3 —X 4 —COOH(其中X 1 和X 4 是键或亚烷基,X 2 和X 3 是键,—O—,—S—,Ar是二价芳香族等),R 2 是可选地由酰氧基和/或羟基取代的烷基,R 3 是烷基,W是卤素原子等,或其盐。该化合物具有降低胆固醇活性和降低甘油三酯活性,用于预防或治疗高脂血症。
  • Hypoxic Radiosensitizers: Substituted Styryl Derivatives
    作者:Abraham Nudelman、Eliezer Falb、Yael Odesa、Naomi Shmueli-Broide
    DOI:10.1002/ardp.19943271004
    日期:——
    A number of novel styryl epoxides, N‐substitutedstyryl‐ethanolamines, N‐mono and N,N′‐bis‐(2‐hydroxyethyl)‐cinnamamides ‐ analogues to the known radiosensitizers RSU‐ 1069, pimonidazole and etanidazole ‐ display selective hypoxic radiosensitizing activity. The styryl group, especially when substituted by electron withdrawing groups, was found to be bioisosteric to the nitroimidazolyl functionality
    许多新型苯乙烯基环氧化物、N-取代-苯乙烯基-乙醇胺、N-单和 N,N'-双-(2-羟乙基)-肉桂酰胺 - 已知放射增敏剂 RSU-1069、哌莫硝唑和依他硝唑的类似物 - 显示选择性缺氧放射增敏活性。发现苯乙烯基,特别是当被吸电子基团取代时,与硝基咪唑基官能团是生物等排的。活性最强的衍生物 2-(2'-硝基苯基)-1-基-环氧乙烷 8a 相对于米索尼达唑显示出 5 的敏化剂增强比 (SER)。
  • The reduction of aromatic nitro groups on solid supports using sodium hydrosulfite (Na2S2O4)
    作者:Randall A Scheuerman、David Tumelty
    DOI:10.1016/s0040-4039(00)00959-x
    日期:2000.8
    An improved method for reducing aromatic nitro compounds on solid-phase supports using sodium hydrosulfite is presented. Conditions have been optimized to enable the use of this reagent for reductions on both polyethyleneglycol-polystyrene (PEG) resins and traditional polystyrene (PS) resins.
    提出了一种使用亚硫酸氢钠还原固相载体上芳族硝基化合物的改进方法。已对条件进行了优化,以使该试剂可用于还原聚乙二醇-聚苯乙烯(PEG)树脂和传统聚苯乙烯(PS)树脂。
  • Colorant compounds
    申请人:Banning H. Jeffrey
    公开号:US20060020141A1
    公开(公告)日:2006-01-26
    Compounds of the formula wherein M is either (1) a metal ion having a positive charge of +y wherein y is an integer which is at least 2, said metal ion being capable of forming a compound with at least two chromogen moieties, or (2) a metal-containing moiety capable of forming a compound with at least two chromogen moieties, z is an integer representing the number of chromogen moieties associated with the metal and is at least 2, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , a, b, c, d, Y, and z are as defined herein, Q − is a COO − group or a SO 3 — group, A is an organic anion, and CA is either a hydrogen atom or a cation associated with all but one of the Q − groups.
    式中的化合物,其中M是一个带有正电荷+y的金属离子,其中y是至少为2的整数,该金属离子能够与至少两个色团基团形成化合物,或者M是一个含金属基团的基团,能够与至少两个色团基团形成化合物,z是表示与金属相关的色团基团数量的整数,至少为2,R1、R2、R3、R4、R5、R6、R7、a、b、c、d、Y和z的定义如上所述,Q-是一个COO-基团或SO3-基团,A是一个有机阴离子,CA是一个氢原子或与除一个Q-基团之外的所有Q-基团相关联的阳离子。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

相关功能分类